CSF-analyses in clinical diagnosis of Creutzfeldt-Jakob disease. A literature review and three cases from routine clinical practice;Likvoranalyser i klinisk diagnostik av Creutzfeldt-Jakobs sjukdom: En litteraturgenomgång och tre fall från den kliniska vardagen

Lakartidningen

Volumn 98, Issue 20, 2001, Pages 2446-2451

  Blennow, Kaj ^a   Lind, Börje ^b   Andersson, Elsa ^c   Andreasen, Niels ^d  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b Geriatriska Kliniken   (Sweden)

^c Psykiatriska Kliniken   (Sweden)

^d Rehabiliteringskliniken   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; TAU PROTEIN;

AGED; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID; CREUTZFELDT JAKOB DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; MIDDLE AGED; PROTEIN CEREBROSPINAL FLUID LEVEL; WESTERN BLOTTING;

AGED; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CEREBROSPINAL FLUID PROTEINS; CREUTZFELDT-JAKOB SYNDROME; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; TAU PROTEINS;

EID: 0035897782     PISSN: 00237205     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Lundberg PO. Ännu bara en början av galna ko-sjukan? Creutz-feldt-Jakobs sjukdom och andra prionsjukdomar: nuläget. Läkartidningen 2001; 98: 19-24.
2. Prusiner SB. The prion diseases. Brain Pathol 1998; 8: 499-513.
3. Johnson RT, Gibbs CJ. Creutzfeldt-Jakob disease and related transmissible spongiform encephalopathies. N Engl J Med 1998;339:1994-2004.
4. Wader T. Två fall av Creutzfeldt-Jakobs sjukdom. Komplex symtomatologi försvårar diagnostiken. Läkartidningen 1997; 94: 3857-60.
5. Zerr I, Pocchiari M, Collins S, Brandel JP, de Pedro Cuesta J, Knight RS et al. Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology 2000; 55: 811-5.
6. Otto M, Wiltfang J, Tumani H, Zerr I, Lantsch M, Kornhuber J et al. Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Neurosci Lett 1997; 225: 210-2.
7. Hansen HC, Zschocke S, Sturenburg HJ, Kunze K. Clinical changes and EEG patterns preceding the onset of periodic sharp wave complexes in Creutzfeldt-Jakob disease. Acta Neurol Scand 1998; 97: 99-106.
8. Steinhoff BJ, Racker S, Herrendorf G, Poser S, Grosche S, Zerr I et al. Accuracy and reliability of periodic sharp wave complexes in Creutzfeldt-Jakob disease. Arch Neurol 1996; 53:162-6.
9. Harrington MG, Merril CR, Asher DM, Gajdusek DC. Abnormal proteins in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. N Engl J Med 1986; 315: 279.
10. Poser S, Mollenhauer B, Krauss A, Zerr I, Steinhoff BJ, Shroeter A et al. How to improve the clinical diagnosis of Creutzfeldt-Jakob disease. Brain 1999; 122: 2345-51.
11. Lemstra AW, van Meegen MT, Vreyling JP, Meijerink PHS, Jansen GH, Bulk S et al. 14-3-3 testing in diagnosing Creutzfeldt-Jakob disease. Neurology 2000; 55: 514-6.
12. Zerr I, Bodemer M, Gefeller O, Otto M, Poser S, Wiltfang J et al. Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann Neurol 1998543: 32-40.
13. Rosenmann H, Meiner Z, Kahana E, Halimi M, Lenetsky E, Abramsky O et al. Detection of 14-3-3 protein in the CSF of genetic Creutzfeldt-Jakob disease. Neurology 1997; 49: 593-5.
14. Goedert M. Tau protein and the neurofibrillary pathology of Alzheimer's disease. Trends Neurosci 1993; 16: 460-5.
15. Van Everbroeck B, Green AJE, Pals P, Martin JJ, Cras P. Decreased levels of amyloid β 1-42 in cerebrospinal fluid of Creutzfeldt-Jakob disease patients. Journal of Alzheimer's Disease 1999; 1:419-29.
16. Blennow K, Wallin A, Ågren H, Spenger C, Siegfried J, Vanmechelen E. Tau protein in cerebrospinal fluid: a biochemical diagnostic marker for axonal degeneration in Alzheimer's disease? Mol Chem Neuropathol 1995; 26: 231-45.
17. Hsich G, Kennedy K, Gibbs CJ, Lee KH, Harrington MG. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissable spongiform encephalopathies. N Engl J Med 1996; 335: 924-30.
18. Blennow K, Minthon L, Wallin A. Nya rön om Alzheimers sjukdom: Gott hopp om att biokemiska markörer kan skärpa diagnostiken. Läkartidningen 2000; 97: 6-10.
19. Andreasen N, Minthon L, Davidsson P, Vanmechelen E, Vanderstichele H, Winblad B et al. Evaluation of CSF-tau and CSF-Aβ42 as diagnostic markers for Alzheimer's disease in clinical practice. Arch Neurol 2001; 58: 373-9.
20. Hulstaert F, Blennow K, Ivanoiu A, Schoonderwaldt HC, Riemenschneider M, De Deyn PP et al. Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF. Neurology 1999; 52: 1555-62.